Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9LQ1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,369
Award facts
- Contract value 100% obligated
- $12,369.49 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $12,369.49 to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 ml pen (2 ml) on January 16, 2026, with an ultimate completion date of January 20, 2026. This is a firm fixed-price, non-set-aside contract with performance at the contractor's facility in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger indefinite delivery contract with DLA Troop Support Medical valued at $999,999,999.00 through December 2031, which serves as a comprehensive global pharmaceutical supply vehicle supporting military healthcare programs worldwide.
Dupixent (dupilumab) is a specialty biologic medication used to treat moderate-to-severe atopic dermatitis and other inflammatory conditions. This delivery order exemplifies the type of specialty pharmaceutical products procured through the DLA's medical supply chain to support military treatment facilities and veterans' healthcare programs. The contract reflects the broader federal strategy of leveraging comprehensive pharmaceutical IDCs to efficiently fulfill essential medical commodity requirements across the Department of Defense healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F9LQ1?
SPE2DR26F9LQ1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 16, 2026.
How much is contract SPE2DR26F9LQ1 worth?
The government has obligated $12,369 on SPE2DR26F9LQ1.
Is contract SPE2DR26F9LQ1 an order under another contract?
Yes. SPE2DR26F9LQ1 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9LQ1 competed?
The extent of competition for SPE2DR26F9LQ1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award